Corpus Intelligence IC Memo — KFH - SAN RAFAEL 2026-04-26 11:17 UTC
IC Memo — KFH - SAN RAFAEL
Investment Committee Memorandum | CA | 116 beds | Grade C | EBITDA uplift $14.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KFH - SAN RAFAEL

CCN 050510 | MARIN, CA | 116 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KFH - SAN RAFAEL is a 116-bed under-performing / distressed in MARIN, CA with $200.0M in net patient revenue and a -31.1% operating margin. The hospital serves a payer mix of 4.0% Medicare, 0.7% Medicaid, and 95.3% commercial.

Thesis: Undervalued. Our ML models identify $14.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -31.1% to -23.7% (+736bps).

Net Revenue HCRIS$200.0M
Current EBITDA COMPUTED$-62.2M
Operating Margin COMPUTED-31.1%
Occupancy HCRIS39.2%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS23.6%
Distress Probability ML47.3%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
188
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -31.1% places it below the state median. Among 188 size-comparable peers (58-232 beds), the median margin is -4.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (58-232), prioritizing same-state peers. 188 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KFH - SAN RAFAEL (Target)CA116$200.0M-31.1%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
COMMUNITY HOSP. MONTEREY PENINCA227$797.2M9.3%
KFH - MANTECACA213$796.8M15.2%
LAC OLIVE VIEW/UCLA MEDICAL CECA225$754.9M-10.5%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%
KFH - WALNUT CREEKCA219$681.0M-3.4%
NORTHBAY HOSPITAL GROUPCA204$676.6M-8.2%
KFH - SAN LEANDROCA216$663.8M10.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$128K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.4M
Clean Claim Rate
$128K
Total EBITDA Uplift$14.7M
Current EBITDA$-62.2M
+ RCM Uplift+$14.7M
Pro Forma EBITDA$-47.4M
Current Margin-31.1%
Pro Forma Margin-23.7%
WC Released (1x)$7.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-95.7M$-262.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-95.7M$-320.2M0.00x-100.0%
Bull Case9.0x11.0x$-86.1M$-302.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-86.1M$-355.6M0.00x-100.0%
Bear Case11.0x10.0x$-105.2M$-305.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-105.2M$-370.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 188 hospitals with 58-232 beds
  • Same-state prioritization (n=189)
  • Comp margins: P25=-20.3% / P50=-4.5% / P75=4.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.